Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand.

[1]  M. Skov,et al.  Identification of CTX-M15-, SHV-28-producing Klebsiella pneumoniae ST15 as an epidemic clone in the Copenhagen area using a semi-automated Rep-PCR typing assay , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[2]  F. Baquero,et al.  Dispersal of Carbapenemase blaVIM-1 Gene Associated with Different Tn402 Variants, Mercury Transposons, and Conjugative Plasmids in Enterobacteriaceae and Pseudomonas aeruginosa , 2009, Antimicrobial Agents and Chemotherapy.

[3]  I. Damjanova,et al.  Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'? , 2008, The Journal of antimicrobial chemotherapy.

[4]  D. Andersson,et al.  The first major extended‐spectrum β‐lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX‐M‐15 , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[5]  G. Daikos,et al.  Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. , 2007, The Journal of antimicrobial chemotherapy.

[6]  V. Jarlier,et al.  Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  E. Koratzanis,et al.  Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece. , 2007, The Journal of antimicrobial chemotherapy.

[8]  N. Woodford,et al.  CTX-M: changing the face of ESBLs in Europe. , 2006, The Journal of antimicrobial chemotherapy.

[9]  P. Raibaud,et al.  R-plasmic transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora , 1980, Infection and immunity.